The Valley Desk

NCT05138458 · Interventional trial

A Study of MT-101 in Subjects With CD5+ Relapsed/Refractory TCL

Overall registry status Suspended

Phase 1 · Phase 2

Conditions Adoptive Cellular Immunotherapy, Cell Therapy, Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Mycosis Fungoides

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov